Product Information
MINOCYCLINE ER 90 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $3.0305 per EA under NDC 67877057630. Its NADAC has been published 75 times since Mar 19, 2025.
FDA first approved this application on Sep 28, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Minocycline Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
90 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877057630
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
11/19/2025
Active Ingredients
MINOCYCLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204453FDA Approved
9/28/2016
TE Code
AB
On Market Since
9/30/2016
Pharmacological Classes
Price Statistics
The NADAC for MINOCYCLINE ER 90 MG TABLET has been published 75 times since Mar 19, 2025, and over the history we have for it it has risen 22.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.0305 per EA |
|---|---|
| All-time high | $3.0305 (Aug 19, 2026) |
| All-time low | $2.4742 (Mar 19, 2025) |
| 52-week high | $3.0305 |
| 52-week low | $2.8131 |
| Median price | $3.0305 |
| Average price | $2.8766 |
| Largest weekly change | +4.5% (Jul 23, 2025) |
| Weeks tracked | 75 |
| Tracking since | Mar 19, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Minocycline Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MINOCYCLINE ER 90 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MINOCYCLINE ER 90 MG TABLET, manufactured by Ascend Laboratories, LLC, is $3.0305 per EA (NDC 67877057630), effective Aug 19, 2026.
How has the price of MINOCYCLINE ER 90 MG TABLET changed over time?
Over the history we have for it, the NADAC for MINOCYCLINE ER 90 MG TABLET has risen 22.5%. It has been tracked across 75 weekly CMS publications since Mar 19, 2025.
What are the highest and lowest recorded NADAC prices for MINOCYCLINE ER 90 MG TABLET?
Since Mar 19, 2025, the NADAC for MINOCYCLINE ER 90 MG TABLET has ranged from a low of $2.4742 (Mar 19, 2025) to a high of $3.0305 (Aug 19, 2026), with a median of $3.0305 per EA.
Are there cheaper alternatives to MINOCYCLINE ER 90 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of MINOCYCLINE ER 90 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MINOCYCLINE ER 90 MG TABLET?
MINOCYCLINE ER 90 MG TABLET (NDC 67877057630) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.